Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring 
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says 
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets 
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review 
Apple Restores Telegram to App Store After Content Policy Violation 
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August 
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel 
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand 
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal 
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat 
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners 
Capital One Says AML Review Led to Closure of Trump Organization Accounts 
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip 
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger 
Global Bioenergies to present at the Microcap investors conference in New-York, on the 10th of April 2018
Evry, France - 06 April 2018 - Global Bioenergies to present at the Microcap investors conference in New-York, on the 10th of April 2018. For the First time in North America, the technology and business model of the company will be exposed in front of a selection of institutional investors.
About GLOBAL BIOENERGIES
Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the performance of its process, to operate its demo plant in Germany, and to prepare the first full-scale plant through a joint venture with Cristal Union, named IBN-One. Global Bioenergies is listed on Euronext Growth Paris (FR0011052257 - ALGBE).
Stay informed! Subscribe to our newsfeed on
www.global-bioenergies.com
Follow us on Twitter: @GlobalBioenergi
Contact
GLOBAL BIOENERGIES
Jean-Baptiste Barbaroux
Chief Corporate Officer
Phone: +33 1 64 98 20 50
[email protected]
Attachment
